MedPath

The study is being done to see whether probiotic (good bacteria) if given to children with autism spectrum disorder has any role to play in improving behaviour and gastro-intestinal symptoms in childre

Phase 3
Not yet recruiting
Conditions
Health Condition 1: F840- Autistic disorder
Registration Number
CTRI/2021/11/038213
Lead Sponsor
utri Newron Pediatrix Private limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All children between the ages of 2-9 years with autism spectrum disorder diagnosed with DSM 5 criteria

All parents who have willingly given an informed written consent

Exclusion Criteria

Brian abnormalities detected by neurological imaging procedures

Neurological syndromes or focal neurological signs

history of documented sequelae of birth asphyxia or preterm less than 28 weeks gestational age or perinatal injury

epilepsy -past or current

significant sensory impairments like deafness/blindness

use of antibiotics within 2 months prior to enrolment

Chronic medical conditions Eg Diabetes, weight and height less than 3rd centile for age, long term use of anti inflammatory use within 2 months prior to enrolment

Organic GI disorders like Gastro-esophageal reflux, inflammatory bowel disease or prior bowel surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of children before probiotic/placebo supplementation by Social responsiveness scale 2, Aberrant behaviour checklist, Gastro-intestinal severity index, Children sleep habits questionnaireTimepoint: at the time of initiation and after 3 months of intervention
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath